Published in Front Behav Neurosci on October 20, 2010
GABAergic inhibition of histaminergic neurons regulates active waking but not the sleep-wake switch or propofol-induced loss of consciousness. J Neurosci (2012) 1.67
The histaminergic network in the brain: basic organization and role in disease. Nat Rev Neurosci (2013) 1.14
Central nervous system regulation of brown adipose tissue. Compr Physiol (2014) 0.93
Wakefulness Is Governed by GABA and Histamine Cotransmission. Neuron (2015) 0.89
The waking brain: an update. Cell Mol Life Sci (2011) 0.86
[(11)C]Doxepin binding to histamine H1 receptors in living human brain: reproducibility during attentive waking and circadian rhythm. Front Syst Neurosci (2012) 0.82
mRNA expression profile of serotonin receptor subtypes and distribution of serotonergic terminations in marmoset brain. Front Neural Circuits (2014) 0.81
Histamine receptor expression, hippocampal plasticity and ammonia in histidine decarboxylase knockout mice. Cell Mol Neurobiol (2011) 0.81
Histaminergic afferent system in the cerebellum: structure and function. Cerebellum Ataxias (2014) 0.79
Histamine and the striatum. Neuropharmacology (2015) 0.77
Waking with the hypothalamus. Pflugers Arch (2011) 0.77
Thioperamide treats neonatal hypoxic-ischemic encephalopathy by postsynaptic H1 receptors. Neural Regen Res (2013) 0.75
Hypothalamic tuberomammillary nucleus neurons: electrophysiological diversity and essential role in arousal stability. J Neurosci (2017) 0.75
Inactivation of the Tuberomammillary Nucleus by GABAA Receptor Agonist Promotes Slow Wave Sleep in Freely Moving Rats and Histamine-Treated Rats. Neurochem Res (2017) 0.75
Hypothalamic regulation of sleep and circadian rhythms. Nature (2005) 8.23
Histamine in the nervous system. Physiol Rev (2008) 3.47
The role of histamine and the tuberomamillary nucleus in the nervous system. Nat Rev Neurosci (2003) 2.71
From waking to sleeping: neuronal and chemical substrates. Trends Pharmacol Sci (2005) 2.59
The physiology of brain histamine. Prog Neurobiol (2001) 2.45
Orexin/hypocretin and histamine: distinct roles in the control of wakefulness demonstrated using knock-out mouse models. J Neurosci (2009) 2.35
Histaminergic transmission in the mammalian brain. Physiol Rev (1991) 2.28
Mice lacking histidine decarboxylase exhibit abnormal mast cells. FEBS Lett (2001) 2.15
Anatomical, physiological, and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioral and sleep-wake control. J Neurosci (2002) 2.10
Identification of sleep-promoting neurons in vitro. Nature (2000) 1.90
Distribution of the histaminergic neuron system in the central nervous system of rats; a fluorescent immunohistochemical analysis with histidine decarboxylase as a marker. Brain Res (1984) 1.80
Convergence and divergence of neurotransmitter action in human cerebral cortex. Proc Natl Acad Sci U S A (1989) 1.65
Neuronal activity of histaminergic tuberomammillary neurons during wake-sleep states in the mouse. J Neurosci (2006) 1.65
Histamine-containing neurons in the rat hypothalamus. Proc Natl Acad Sci U S A (1984) 1.63
Neuronal activity of orexin and non-orexin waking-active neurons during wake-sleep states in the mouse. Neuroscience (2008) 1.62
Convergent excitation of dorsal raphe serotonin neurons by multiple arousal systems (orexin/hypocretin, histamine and noradrenaline). J Neurosci (2002) 1.47
Modulation of neuronal firing mode in cat and guinea pig LGNd by histamine: possible cellular mechanisms of histaminergic control of arousal. J Neurosci (1991) 1.31
Is the histaminergic neuron system a regulatory center for whole-brain activity? Trends Neurosci (1991) 1.30
Histamine regulates activities of neurons in the ventrolateral preoptic nucleus. J Physiol (2010) 1.26
Brain structures and mechanisms involved in the control of cortical activation and wakefulness, with emphasis on the posterior hypothalamus and histaminergic neurons. Sleep Med Rev (2000) 1.26
The physiological and pathophysiological roles of neuronal histamine: an insight from human positron emission tomography studies. Pharmacol Ther (2006) 1.22
Locus coeruleus neuronal activity during the sleep-waking cycle in mice. Neuroscience (2010) 1.21
The monoamine innervation of rat cerebral cortex: synaptic and nonsynaptic axon terminals. Neuroscience (1978) 1.19
Histaminergic descending inputs to the mesopontine tegmentum and their role in the control of cortical activation and wakefulness in the cat. J Neurosci (1996) 1.16
Morphological analysis of the tuberomammillary nucleus in the rat brain: delineation of subgroups with antibody against L-histidine decarboxylase as a marker. J Comp Neurol (1987) 1.10
Characterization and mapping of sleep-waking specific neurons in the basal forebrain and preoptic hypothalamus in mice. Neuroscience (2009) 1.06
Involvement of histamine in the control of the waking state. Life Sci (1993) 1.00
Multiple neurotransmitters in the tuberomammillary nucleus: comparison of rat, mouse, and guinea pig. J Comp Neurol (1992) 0.99
Hypothalamic control of sleep. Sleep Med (2007) 0.99
Coexistence of adenosine deaminase, histidine decarboxylase, and glutamate decarboxylase in hypothalamic neurons of the rat. J Neurosci (1985) 0.94
Cholinergic nucleus basalis neurons are excited by histamine in vitro. Neuroscience (1995) 0.93
Hypothalamic gamma-aminobutyric acid neurons project to the neocortex. Science (1983) 0.93
Serotonergic dorsal raphe neurons cease firing by disfacilitation during paradoxical sleep. Neuroreport (2000) 0.89
Electrophysiological properties of catecholaminergic neurons in the norepinephrine-deficient mouse. Neuroscience (2006) 0.84
Fine structure of histaminergic neurons in the caudal magnocellular nucleus of the rat as demonstrated by immunocytochemistry using histidine decarboxylase as a marker. J Comp Neurol (1984) 0.83
GABA-like immunoreactivity in the tuberomammillary nucleus: an electron microscopic study in the rat. J Comp Neurol (1991) 0.82
Modulation of presumed cholinergic mesopontine tegmental neurons by acetylcholine and monoamines applied iontophoretically in unanesthetized cats. Neuroscience (2000) 0.81
Effects of microdialysis application of monoamines on the EEG and behavioural states in the cat mesopontine tegmentum. Eur J Neurosci (1999) 0.81
Immunohistochemical evidence for the coexistence of histidine decarboxylase-like and glutamate decarboxylase-like immunoreactivities in nerve cells of the magnocellular nucleus of the posterior hypothalamus of rats. Proc Natl Acad Sci U S A (1984) 0.80
Neuronal colocalization of adenosine deaminase, monoamine oxidase, galanin and 5-hydroxytryptophan uptake in the tuberomammillary nucleus of the rat. Brain Res Bull (1986) 0.77
Orexin/hypocretin and histamine: distinct roles in the control of wakefulness demonstrated using knock-out mouse models. J Neurosci (2009) 2.35
Mechanism of action of T-705 against influenza virus. Antimicrob Agents Chemother (2005) 2.32
Anatomical, physiological, and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioral and sleep-wake control. J Neurosci (2002) 2.10
T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections. Antiviral Res (2009) 1.82
Favipiravir (T-705), a novel viral RNA polymerase inhibitor. Antiviral Res (2013) 1.79
Neuronal activity of histaminergic tuberomammillary neurons during wake-sleep states in the mouse. J Neurosci (2006) 1.65
T-705 (favipiravir) activity against lethal H5N1 influenza A viruses. Proc Natl Acad Sci U S A (2009) 1.48
The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders. Trends Pharmacol Sci (2004) 1.27
KRN951, a highly potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, has antitumor activities and affects functional vascular properties. Cancer Res (2006) 1.16
An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin-/- mice and patients. Neurobiol Dis (2007) 1.15
Novel potent orally active selective VEGFR-2 tyrosine kinase inhibitors: synthesis, structure-activity relationships, and antitumor activities of N-phenyl-N'-{4-(4-quinolyloxy)phenyl}ureas. J Med Chem (2005) 1.14
Brain histamine and schizophrenia: potential therapeutic applications of H3-receptor inverse agonists studied with BF2.649. Biochem Pharmacol (2007) 1.11
Intracellular metabolism of favipiravir (T-705) in uninfected and influenza A (H5N1) virus-infected cells. J Antimicrob Chemother (2009) 1.06
Protean agonism at histamine H3 receptors in vitro and in vivo. Proc Natl Acad Sci U S A (2003) 1.04
Brainstem and spinal cord circuitry regulating REM sleep and muscle atonia. PLoS One (2011) 1.00
Mechanism of action of T-705 ribosyl triphosphate against influenza virus RNA polymerase. Antimicrob Agents Chemother (2013) 1.00
Orexinergic projections to the cat midbrain mediate alternation of emotional behavioural states from locomotion to cataplexy. J Physiol (2005) 0.98
KRN633: A selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase that suppresses tumor angiogenesis and growth. Mol Cancer Ther (2004) 0.97
Excitation of histaminergic tuberomamillary neurons by thyrotropin-releasing hormone. J Neurosci (2009) 0.96
Identification and characterization of a sleep-active cell group in the rostral medullary brainstem. J Neurosci (2012) 0.96
Application of histamine or serotonin to the hypoglossal nucleus increases genioglossus muscle activity across the wake-sleep cycle. J Sleep Res (2009) 0.91
A new animal model of obstructive sleep apnea responding to continuous positive airway pressure. Sleep (2011) 0.91
Effects of the H3 receptor inverse agonist thioperamide on cocaine-induced locomotion in mice: role of the histaminergic system and potential pharmacokinetic interactions. Psychopharmacology (Berl) (2008) 0.90
L-Dopa activates histaminergic neurons. J Physiol (2011) 0.87
Requirement of tryptophan hydroxylase during development for maturation of sensorimotor gating. J Mol Biol (2006) 0.87
Pitolisant, an inverse agonist of the histamine H3 receptor: an alternative stimulant for narcolepsy-cataplexy in teenagers with refractory sleepiness. Clin Neuropharmacol (2012) 0.86
The waking brain: an update. Cell Mol Life Sci (2011) 0.86
Impact of obesity in children with narcolepsy. CNS Neurosci Ther (2013) 0.85
The psychostimulant and rewarding effects of cocaine in histidine decarboxylase knockout mice do not support the hypothesis of an inhibitory function of histamine on reward. Psychopharmacology (Berl) (2006) 0.84
Covalent enzyme immobilization by poly(ethylene glycol) diglycidyl ether (PEGDE) for microelectrode biosensor preparation. Biosens Bioelectron (2011) 0.83
Enhanced histaminergic neurotransmission and sleep-wake alterations, a study in histamine H3-receptor knock-out mice. Neuropsychopharmacology (2013) 0.82
Influence of arousal level for functional magnetic resonance imaging (fMRI) study: simultaneous recording of fMRI and electroencephalogram. Psychiatry Clin Neurosci (2002) 0.81
Spontaneous arousability in prone and supine position in healthy infants. Sleep (2006) 0.81
Quality of life in children with narcolepsy. CNS Neurosci Ther (2014) 0.81
Histamine receptor expression, hippocampal plasticity and ammonia in histidine decarboxylase knockout mice. Cell Mol Neurobiol (2011) 0.81
QT interval prolongation in future SIDS victims: a polysomnographic study. Sleep (2008) 0.81
Maturation of spontaneous arousals in healthy infants. Sleep (2008) 0.80
Waking action of ursodeoxycholic acid (UDCA) involves histamine and GABAA receptor block. PLoS One (2012) 0.80
The orexinergic synaptic innervation of serotonin- and orexin 1-receptor-containing neurons in the dorsal raphe nucleus. Regul Pept (2005) 0.78
[Associations between workplace bullying, harassment, and stress reactions of professional caregivers at welfare facilities for the elderly in Japan]. Sangyo Eiseigaku Zasshi (2011) 0.78
Occult nighttime hypertension in daytime normotensive older patients with obstructive sleep apnea. J Am Med Dir Assoc (2012) 0.78
Waking with the hypothalamus. Pflugers Arch (2011) 0.77
Effects of GF-015535-00, a novel α1 GABA A receptor ligand, on the sleep-wake cycle in mice, with reference to zolpidem. Sleep (2012) 0.77
MPTP animal model of Parkinsonism: dopamine cell death or only tyrosine hydroxylase impairment? A study using PET imaging, autoradiography, and immunohistochemistry in the cat. CNS Neurosci Ther (2012) 0.77
Multiple deletions in mitochondrial DNA in a patient with progressive external ophthalmoplegia, leukoencephalopathy and hypogonadism. Intern Med (2014) 0.76
Fewer spontaneous arousals in infants with apparent life-threatening event. Sleep (2011) 0.76
Gene expression of lymphocyte prolactin receptor was suppressed in lactating mothers. Tokai J Exp Clin Med (2010) 0.76
Firing properties of neurones in the laterodorsal hypothalamic area during sleep and wakefulness. Psychiatry Clin Neurosci (2002) 0.76
Inflammatory pain models with capsaicin or glutamate injections: are they comparable and reproducible? Clin Exp Pharmacol Physiol (2014) 0.75
Usefulness of combined PET/CT for patient with epithelial ovarian cancer showing recurrence based on tumor marker CA125. Tokai J Exp Clin Med (2007) 0.75
[In vitro combination effect of pazufloxacin with various antibiotics against Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus]. Jpn J Antibiot (2002) 0.75
[Sequence comparison of the hemagglutinin gene of the duck-origin H9N2 subtype avian influenza viruses]. Bing Du Xue Bao (2012) 0.75
Evaluation of 25 years of Uterine Cervical Cancer Screening at Tokai University Hospital Health Evaluation and Promotion Center. Tokai J Exp Clin Med (2006) 0.75
Asymptomatic multiple splenic cysts in a pulmonary neoplasm patient. J Nippon Med Sch (2012) 0.75
[The brain histamine H3 receptors: sleep-wake control and novel therapeutic targets for sleep disorders]. Sheng Li Ke Xue Jin Zhan (2014) 0.75
Strategy of controlling the volumetric loading rate to promote hydrogen-production performance in a mesophilic-kitchen-waste fermentor and the microbial ecology analyses. Bioresour Technol (2011) 0.75
Improvement by solid dispersion of the bioavailability of KRN633, a selective inhibitor of VEGF receptor-2 tyrosine kinase, and identification of its potential therapeutic window. Mol Cancer Ther (2006) 0.75